Michael P Stansky

TLSI

Michael P Stansky serves as director at TriSalus Life Sciences, Inc. (TLSI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$3.01M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$3.01M

Companies Traded

TLSI

Active Period

Feb 2026 – May 2026

2 total trades

Most Recent

Buy TLSI

May 18, 2026 · $1.52M

Michael P Stansky's Insider Trading at TriSalus Life Sciences, Inc. (TLSI)

Buys

2 · $3.01M

Sells

0 · $0.00

Total Shares Bought

971,098

Total Shares Sold

TLSI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 18, 2026	Buy	610,000	$2.50	$1.52M	1,240,722
Feb 23, 2026	Buy	361,098	$4.10	$1.48M	0

Related Insiders

Richard Marshak

officer: Chief Commercial Officer

TLSISell · May 19, 2026

Gary B. Gordon

director

TLSIBuy · May 18, 2026

Mats Wahlstrom

director

TLSIBuy · May 18, 2026

David Patience

officer: Chief Financial Officer

TLSIBuy · May 18, 2026

Mary T Szela

director, officer: CEO and President

TLSIBuy · May 18, 2026

Jennifer Stevens

officer: Chief Regulatory Officer

TLSISell · Mar 20, 2026

Bryan F. Cox

officer: Chief of Research

TLSISell · Mar 20, 2026

Jodi Devlin

officer: Chief of Clinical Operations

TLSISell · Mar 20, 2026

Explore More Insider Trading Data

TLSI Insider Trading Activity

View all insider trades at TriSalus Life Sciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity